Latest 10-K annual reports

NASDAQ
Syntec Optics Holdings, Inc. reported a net loss of $2.5 million for fiscal year 2024, a significant decline from the prior year's profit, alongside identified material weaknesses in internal controls and NASDAQ delinquency alerts.
NASDAQ
Tianci International, Inc. reported an 8% revenue increase to $9.28 million for fiscal year 2025, but posted a significant net loss of $2.68 million and a 57% drop in gross profit, following its Nasdaq IPO and strategic expansion into mineral trading.
NASDAQ
Micron Technology reports a significant rebound in fiscal year 2025, driven by robust AI demand, leading to substantial increases in revenue and profitability across its memory and storage segments.
OID
Artisan Consumer Goods, Inc. reported increased losses and a significant accumulated deficit for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern.
OID
Xeriant, Inc. reports continued operating losses and significant legal challenges while advancing its eco-friendly NEXBOARD construction panel and aerospace technologies.
NYSE
United Natural Foods, Inc. (UNFI) reported a net loss of $118 million for fiscal year 2025, impacted by a cybersecurity incident and increased restructuring costs, despite growth in its Natural segment.
MedWellAI, Inc. reported a strategic shift from digital asset mining to AI-driven healthcare, alongside substantial net losses and a going concern warning for the fiscal year ended June 30, 2025.
OQB
Vivic Corp. reported a substantial net loss for fiscal year 2025, exiting the Taiwan market to focus on the United States and Southeast Asia amidst going concern doubts.
NASDAQ
Kentucky First Federal Bancorp reported a net income of $181,000 for fiscal year 2025, a significant improvement from the prior year's net loss, driven by increased net interest income and non-interest income.
OQB
Nexscient, Inc. reported no revenue and a net loss of $529,704 for fiscal year 2025, while strategically acquiring an AI software and planning further capital raises.
OID
PreAxia Health Care Payment Systems Inc. filed an amended annual report, revealing a strategic pivot into AI-powered personal finance with its new Zane subsidiaries and significant capital requirements amidst ongoing losses.
NASDAQ
The InterGroup Corporation reported a reduced net loss for fiscal year 2025, driven by improved hotel performance and a successful debt refinancing, while addressing Nasdaq compliance and internal control weaknesses.
OTC.Pink
Portsmouth Square, Inc. reports a reduced net loss for fiscal year 2025, driven by a successful debt refinancing and improved hotel operating metrics in San Francisco.
Dalrada Financial Corporation reports recurring losses and negative working capital, raising substantial doubt about its ability to continue as a going concern, despite some revenue growth in key segments.
OTC.Pink
Blackwell 3D Construction Corp. filed an amended annual report to remove shell company references, highlighting its ongoing development in 3D construction technology despite significant financial losses and a going concern warning.
NYSE
Ready Capital Corporation filed an amendment to its 2024 Annual Report, primarily correcting certification errors, while detailing a strategic shift to LMM commercial real estate and small business lending, alongside significant financial performance changes including a net loss.
Damon Inc. reports significant losses and a going concern warning, with its shares delisted from Nasdaq and now trading on the OTCID Basic Market, as it continues electric motorcycle development.
AMEX
AtlasClear Holdings, Inc. filed an amended annual report for fiscal year 2025, reporting a significant shift to net income despite ongoing liquidity concerns and internal control weaknesses.
The Glimpse Group, Inc. reported a significant reduction in net loss and increased revenue for fiscal year 2025, driven by a strategic shift to Spatial Computing and divestiture of non-core assets.
NYSE
IDT Corporation's fiscal 2025 annual report highlights significant revenue and income growth across its fintech and communications segments, driven by strategic expansion and operational efficiencies.
NASDAQ
Propanc Biopharma, a biopharmaceutical company, reported a significant increase in net loss to $58.9 million for fiscal year 2025, driven by substantial stock-based compensation, while advancing its lead cancer drug candidate, PRP, towards Phase Ib clinical trials.
NASDAQ
Beneficient reported a significantly reduced net loss for fiscal year 2025, driven by legal settlements and lower operating expenses, though substantial doubt about its ability to continue as a going concern persists.
NYSE
ReposiTrak, Inc. announced an 11% revenue increase and a 25% rise in net income for fiscal year 2025, alongside a 10% dividend increase and continued Preferred Stock redemptions.
NASDAQ
Amesite Inc. shifts its core business to AI-powered healthcare solutions with NurseMagic, reporting reduced net losses but facing substantial doubt about its ability to continue as a going concern.
AMEX
AtlasClear Holdings, Inc. reported a net income of $5.75 million for the fiscal year ended June 30, 2025, a significant improvement from the prior year's substantial loss, despite ongoing liquidity challenges and a 'going concern' warning.
NASDAQ
MacKenzie Realty Capital, Inc. reported a significantly wider net loss for fiscal year 2025, driven by increased expenses and an impairment loss, leading to the suspension of common stock dividends.
OQB
VIP Play, Inc. reported a net loss of $18.9 million for fiscal year 2025, a significant improvement from the prior year, but faces substantial doubt about its ability to continue as a going concern without further financing.
OQB
Bion Environmental Technologies, Inc. reports significant financial challenges and leadership changes, pivoting its strategy towards bolt-on ammonia control solutions after writing down its Fair Oaks demonstration facility.
Neuphoria Therapeutics Inc. reports progress in its clinical pipeline for neuropsychiatric disorders, including BNC210 in Phase 3 for SAD and Phase 2b/3 for PTSD, alongside a $15 million milestone payment from Merck.
OQB
Okmin Resources, Inc. reported a net loss of $597,167 for fiscal year 2025, reduced its Blackrock JV interest, and increased its stake in the Pushmataha Gas Field, while facing significant going concern doubts and capital constraints.